Tempus AI Newsroom

Tempus Announces The Launch Of FDA-Approved XT CDx Test, Now Available For All Ordering Clinicians Nationwide

Benzinga21:34

Express News | Tempus Announces the National Launch of FDA-Approved Xt Cdx Test

Breakings21:30

Tempus Announces the National Launch of FDA-Approved XT CDx Test

Businesswire21:30

Loop Capital Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $52

Futu NewsJan 14 21:31 · Ratings

Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

BusinesswireJan 14 21:30

Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock

BenzingaJan 14 21:00

TEM Stock Declines Following Preliminary Q4 Sales Miss

Zacks Jan 14 20:35

Needham Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $56

Futu NewsJan 14 20:31 · Ratings

Needham Reiterates Buy on Tempus AI, Maintains $56 Price Target

BenzingaJan 14 19:41 · Ratings

Tempus AI Analyst Ratings

BenzingaJan 14 19:37 · Ratings

Cathie Wood's ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss

TipRanksJan 14 18:02

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025

BenzingaJan 14 15:27

Here's Why Tempus AI, Inc (TEM) Is Among Monday's Top Losers

Yahoo FinanceJan 14 13:57

BofA Securities Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $54

Futu NewsJan 14 05:31 · Ratings

Sector Update: Tech Stocks Decline Late Afternoon

MT NewswiresJan 14 04:58

Sector Update: Tech

MT NewswiresJan 14 04:39

Tempus AI: Balancing Promising Growth With Current Performance Shortfalls

TipRanksJan 14 04:37

Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations

WSJJan 13 23:17

Tempus AI Reports Strong 2024 Revenue Growth

TipRanksJan 13 22:06

Tempus AI | 8-K: Tempus Announces Preliminary Fourth Quarter and Full Year 2024 Results

SECJan 13 21:47 · Announcements